Trials / Terminated
TerminatedNCT00390975
Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis
An Open-label Pilot Trial to Assess the Effect of Tegaserod on Improvement of Gastric Emptying in Patients With Diabetic Gastroparesis and Upper Gastrointestinal Symptoms
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess gastric emptying in patients with symptoms of diabetic gastroparesis treated with tegaserod over 2 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tegaserod |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2006-10-23
- Last updated
- 2012-05-04
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00390975. Inclusion in this directory is not an endorsement.